26
|
Losada C, López M, Gutiérrez F, Guerra M. 2073 – Retinopathy induced by zuclopentixol depot: A case report. Eur Psychiatry 2013. [DOI: 10.1016/s0924-9338(13)76978-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
27
|
Navinés R, Gutiérrez F, Subirà S, Obiols J, Binelly C, Martín-Santos R. 1872 – Comorbidity between panic disorder with and without co-occurring depression and personality disorders: a systematic review. Eur Psychiatry 2013. [DOI: 10.1016/s0924-9338(13)76831-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/26/2022] Open
|
28
|
Ramos JM, Masiá M, Durán R, Gutiérrez F. Idiopathic ileocolitis with perforation associated with HIV infection: thalidomide treatment. Int J STD AIDS 2012; 23:830-2. [DOI: 10.1258/ijsa.2012.012062] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
Idiopathic cutaneous ulcers, oesophageal ulcers and severe ulcerative ileocolitis occurred in a human immunodeficiency virus (HIV)-infected patient early after the initiation of combination antiretroviral therapy. This massive inflammatory process led to acute colonic perforation on two occasions. The disease was refractory to standard therapy, but responded successfully to thalidomide. Here, we discuss the potential benefits of thalidomide in refractory inflammatory processes in HIV-infected patients.
Collapse
|
29
|
Monge S, Guillot V, Alvarez M, Peña A, Viciana P, García-Bujalance S, Pérez Elias M, Iribarren J, Gutiérrez F, Itziar Casado M, Garcia F, CoRIS. Analysis of transmitted drug resistance in Spain in the years 2007–2010 documents a decline in mutations to the non-nucleoside drug class. Clin Microbiol Infect 2012; 18:E485-90. [DOI: 10.1111/1469-0691.12011] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
30
|
Sánchez-Doblado F, Domingo C, Gómez F, Sánchez-Nieto B, Muñiz JL, García-Fusté MJ, Expósito MR, Barquero R, Hartmann G, Terrón JA, Pena J, Méndez R, Gutiérrez F, Guerre FX, Roselló J, Núñez L, Brualla-González L, Manchado F, Lorente A, Gallego E, Capote R, Planes D, Lagares JI, González-Soto X, Sansaloni F, Colmenares R, Amgarou K, Morales E, Bedogni R, Cano JP, Fernández F. Estimation of neutron-equivalent dose in organs of patients undergoing radiotherapy by the use of a novel online digital detector. Phys Med Biol 2012; 57:6167-91. [DOI: 10.1088/0031-9155/57/19/6167] [Citation(s) in RCA: 39] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
31
|
García-Puente J, Arribas J, Gutiérrez F, Taboada R, Jiménez A, Lahoz A, Pérez-Andreu J, Albaladejo P, Lucas J, Lorenzo M, Ray V, Parra J, Arcas R. 300. Cirugía de recambio valvular aórtico con prótesis biológica autoexpandible perceval s. experiencia inicial. CIRUGIA CARDIOVASCULAR 2012. [DOI: 10.1016/s1134-0096(12)70597-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
32
|
García-Puente J, Arribas J, Gutiérrez F, Taboada R, Jiménez A, Lahoz A, Pérez-Andreu J, Albaladejo P, Lucas J, Lorenzo M, Ray V, Parra J, Arcas R. 335. Cirugía de recambio valvular aórtico con prótesis biológica autoexpandible Perceval S. experiencia inicial. CIRUGIA CARDIOVASCULAR 2012. [DOI: 10.1016/s1134-0096(12)70632-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
|
33
|
Olmo M, Saumoy M, Alonso-Villaverde C, Peñaranda M, Gutiérrez F, Romeu J, Larrousse M, Curto J, Domingo P, Oteo JA, Vila A, Podzamczer D. Impact of antiretroviral therapy interruption on plasma biomarkers of cardiovascular risk and lipids: 144-week final data from the STOPAR study. HIV Med 2012; 13:488-98. [PMID: 22416676 DOI: 10.1111/j.1468-1293.2012.01000.x] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 01/12/2012] [Indexed: 11/29/2022]
Abstract
OBJECTIVE The aim of the study was to investigate changes in plasma biomarkers of cardiovascular risk and lipids in a CD4-guided antiretroviral therapy interruption study. METHODS This was a substudy of a prospective, randomized, multicentre treatment interruption study. At months 12, 24 and 36, monocyte chemotactic protein-1 (MCP-1), soluble vascular cell adhesion molecule-1 (sVCAM-1), interleukin-6 (IL-6), interleukin-8 (IL-8), soluble CD40 ligand (sCD40L), soluble P-selectin (sP-selectin), and tissue plasminogen activator (t-PA) were measured using a multiplex cytometric bead-based assay. Total cholesterol (total-c), high-density lipoprotein cholesterol (HDL-c) and triglycerides (TG) were determined using standard methods. RESULTS Fifty-four patients were included in the study [34 in the treatment continuation (TC) arm and 20 in the treatment interruption (TI) arm]. There were no differences at baseline between the groups, except in CD4 cell count, which was higher in the TI arm (P = 0.026), and MCP-1, which was higher in the TC arm (P = 0.039). MCP-1 and sVCAM-1 were increased relative to baseline at the three study time-points in the TI arm, with no changes in the TC arm. Soluble CD40L and sP-selectin were increased at month 36 in both arms, with a greater increase in the TI arm (P = 0.02). t-PA was increased in both arms at the three time-points. Total-c, HDL-c and low-density lipoprotein cholesterol (LDL-c) were decreased in the TI arm at the three time-points, with no changes in the total-c/HDL-c ratio. HIV viral load positively correlated with MCP-1 at months 12 and 24. Regression analysis showed a significant negative association of HDL-c with MCP-1 and sVCAM-1. CONCLUSIONS A significant increase in cardiovascular risk biomarkers persisting over the prolonged study period was seen in the TI arm. This factor may contribute to the increased cardiovascular risk observed in previous studies.
Collapse
|
34
|
Masiá M, Padilla S, Robledano C, López N, Ramos JM, Gutiérrez F. Early changes in parathyroid hormone concentrations in HIV-infected patients initiating antiretroviral therapy with tenofovir. AIDS Res Hum Retroviruses 2012; 28:242-6. [PMID: 21639815 DOI: 10.1089/aid.2011.0052] [Citation(s) in RCA: 56] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Initiation of combined antiretroviral therapy (cART) is associated with bone loss, which may be more intense with regimens including tenofovir. The underlying mechanisms are not well understood. Cross-sectional data have linked tenofovir with higher parathyroid hormone (PTH) concentrations in patients with vitamin D deficiency. We performed a longitudinal study with a 48-week follow-up to evaluate sequential changes in PTH and 25-hydroxyvitamin D [25(OH)D] levels in patients starting cART with either tenofovir/emtricitabine or abacavir/lamivudine. Fifty-seven patients were included, 31 initiating tenofovir/emtricitabine and 26 initiating abacavir/lamivudine. Median PTH levels turned out to be significantly higher among tenofovir/emtricitabine users at week 4 (p=0.01), week 24 (p=0.008), and week 36 (p=0.02), and were above the upper limits of normal values (ULN) at weeks 24, 36, and 48 only in patients receiving tenofovir/emtricitabine. 25(OH)D, serum and urine calcium and phosphate, and renal-tubular maximum reabsorption of phosphate to the glomerular filtration rate (TmP/GFR) levels did not differ between the two treatment arms over the study period. Among tenofovir/emtricitabine users, median (interquartile range) PTH concentrations were significantly higher in patients with suboptimal 25(OH)D levels (<30 μg/liter) at week 24 [63 (57.8-82.4) ng/liter vs. 54.3 (34.4-63.067.5) ng/liter, p=0.05] and week 48 [67.5 (59.6-86.0) ng/liter vs. 41.9 (37.3-68.8) ng/liter, p=0.03]. A multivariable logistic regression model showed that tenofovir/emtricitabine use was an independent predictor of high PTH levels (≥53 ng/liter). Starting cART with tenofovir regimens is associated with an elevation in PTH plasma concentrations soon after introducing the drug. Suboptimal baseline 25(OH)D levels increase the risk of developing secondary hyperparathyroidism among tenofovir users.
Collapse
|
35
|
Ramos J, Milla A, Rodríguez J, Gutiérrez F. Rubella immune status among immigrant and nonimmigrant women in Spain. J Med Virol 2012; 84:548-50. [DOI: 10.1002/jmv.23195] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
36
|
Tejero-Delgado M, Guerrero A, Hernández E, Martín-Polo J, Martín-Serradilla J, Gutiérrez F, Iglesias F, Sánchez-Barranco F, Laherrán E. Neuropatía periférica como forma de presentación de poliangeítis microscópica. Neurologia 2011; 26:312-4. [DOI: 10.1016/j.nrl.2010.09.018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/07/2010] [Revised: 07/26/2010] [Accepted: 09/05/2010] [Indexed: 10/18/2022] Open
|
37
|
Guerrero A, Tejero M, Gutiérrez F, Martín-Polo J, Iglesias F, Laherran E, Martín-Serradilla J, Merino S. Influence of APOE gene polymorphisms on interferon-beta treatment response in multiple sclerosis. NEUROLOGÍA (ENGLISH EDITION) 2011. [DOI: 10.1016/s2173-5808(11)70029-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/16/2022] Open
|
38
|
Tejero-Delgado M, Guerrero A, Hernández E, Martín-Polo J, Martín-Serradilla J, Gutiérrez F, Iglesias F, Sánchez-Barranco F, Laherrán E. Peripheral neuropathy as a first sign of microscopic polyangiitis. NEUROLOGÍA (ENGLISH EDITION) 2011. [DOI: 10.1016/s2173-5808(11)70067-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/15/2022] Open
|
39
|
Guerrero AL, Tejero MA, Gutiérrez F, Martín-Polo J, Iglesias F, Laherran E, Martín-Serradilla JI, Merino S. Influence of APOE gene polymorphisms on interferon-beta treatment response in multiple sclerosis. Neurologia 2010; 26:137-42. [PMID: 21163235 DOI: 10.1016/j.nrl.2010.06.003] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/23/2010] [Revised: 05/25/2010] [Accepted: 06/03/2010] [Indexed: 12/21/2022] Open
Abstract
OBJECTIVE Clinical trials with interferon beta in relapsing remitting multiple sclerosis (RRMS) have demonstrated a reduction in the relapse rate. Nevertheless, not all patients respond to this treatment, although there is no consensus regarding the definition of response to therapy. The reasons for this failure are not known but genetic factors probably influence this, as has been previously shown with Interleukin 10 or Interferon gamma polymorphisms. The role of apolipoprotein E (APOE) gene in MS has been investigated and does not appear to increase risk for MS or influence disease severity. Interestingly APOE variation influences response to cholinesterase inhibitor treatment in Alzheimer disease or to statins in hypercholesterolemia. This might have future implications for MS. MATERIAL AND METHODS We retrospectively reviewed 38 RRMS patients (32 females and 6 males) treated with interferon beta (INFbeta) over at least two years. Criteria for treatment were uniform accordingly to an "Advisory Committee for the Treatment of Multiple Sclerosis". We collected data variables including age, age of onset, clinical type or disease duration. Patients were classified, two years after the start of treatment, as responders and non-responders based upon clinical criteria available in the literature, which rely on the presence of relapses, increase of disability, or both. APOE genotype was determined from blood samples using validated polymerase chain reaction methods. Correlation between patient responding status with allele E2 or E4 was tested. RESULTS A total of 20 patients (52.6%) received subcutaneous INFbeta1b (Betaferón(®)), 13 (34.2%) INFbeta1a intramuscular (Avonex(®)), and 5 (13.2%) subcutaneous INFbeta1a (Rebif(®)). We found 2 patients (5.2%) heterozygous for the E2 allele and 9 (23.7%) for the E4 allele. No patient was homozygous for E2 or E4. Comparison of patients with and without E2 or E4 allele showed no significant differences in any of the ten therapy response variables assessed. CONCLUSION Findings of a recent meta-analysis have not supported a role for APOE in MS susceptibility or severity. We have not found, in our data, any influence of this gene in the RRMS response to INFbeta. However, larger series would be required to validate these results.
Collapse
|
40
|
Hurtado R, López-García P, Manuel-Ramos J, Gutiérrez F. Meningitis tras una mordedura de perro. Enferm Infecc Microbiol Clin 2010; 28:646-8. [DOI: 10.1016/j.eimc.2009.08.004] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/16/2009] [Revised: 08/19/2009] [Accepted: 08/26/2009] [Indexed: 11/28/2022]
|
41
|
Aparicio R, Gutiérrez F, Rodríguez J. A chemometrics study of analytical panels in virgin olive oil. An approach for evaluating panels in training. GRASAS Y ACEITES 2010. [DOI: 10.3989/gya.1991.v42.i3.1245] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
42
|
Morales MT, Aparicio R, Gutiérrez F. Técnicas de aislamiento y concentración de volátiles de aceites vegetales. GRASAS Y ACEITES 2010. [DOI: 10.3989/gya.1992.v43.i3.1170] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
43
|
Ramos JM, García-Sepulcre MF, Masiá M, Brotons A, Grau MC, Gutiérrez F. Listeria monocytogenes infection in patients with inflammatory bowel diseases receiving anti-tumor necrosis factor therapy. REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS 2010; 102:614-6. [DOI: 10.4321/s1130-01082010001000014] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
44
|
de la Tabla VO, Antequera P, Masiá M, Ros P, Martin C, Gazquez G, Buñuel F, Sánchez V, Robledano C, Gutiérrez F. Clinical evaluation of rapid point-of-care testing for detection of novel influenza A (H1N1) virus in a population-based study in Spain. Clin Microbiol Infect 2010; 16:1358-61. [DOI: 10.1111/j.1469-0691.2010.03159.x] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
45
|
Gutiérrez F, Bernal E, Masiá M. Considerations on ankle-brachial index interpretation in HIV-1 infected patients. HIV Med 2010; 10:395; author reply 395-6. [PMID: 19538360 DOI: 10.1111/j.1468-1293.2009.00732.x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
46
|
Enríquez R, Sirvent A, Andrada E, Escolano C, Rodríguez J, Millán I, Gutiérrez F, Amorós F. Cryoglobulinemic glomerulonephritis in chronic hepatitis B infection. Ren Fail 2010; 32:518-22. [DOI: 10.3109/08860221003675252] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
47
|
Torres A, Garcia-Esteve L, Navarro P, Tarragona M, Imaz M, Gutiérrez F, Santos C, Ascaso C, Martin-Santos R, Subirà S. P02-397 - Personality profile or postraumatic stress disorder? personality characteristics in women victim of chronic intimate partner violence. Eur Psychiatry 2010. [DOI: 10.1016/s0924-9338(10)71399-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/19/2022] Open
|
48
|
Tabeada R, Albaladejo P, Arribas J, Valdés M, Saura D, Pinar E, Gutiérrez F, García-Puente J, Jiménez A, Ray V, Arcas R. 223. Experiencia inicial con el implante de prótesis aórticas vía transfemoral. CIRUGIA CARDIOVASCULAR 2010. [DOI: 10.1016/s1134-0096(10)70686-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022] Open
|
49
|
Pérez Andreu J, Arribas J, Pascual D, Cabañas V, Gutiérrez F, García-Puente J, Jiménez A, Ray V, Parra J, García Real J, Arcas R. 116. Factores de riesgo para transfusión de concentrados de hematíes en cirugía de revascularización miocárdica. CIRUGIA CARDIOVASCULAR 2010. [DOI: 10.1016/s1134-0096(10)70767-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022] Open
|
50
|
Verdes JM, Moraña JA, Battes D, Gutiérrez F, Guerrero F, Goicoa A, Fidalgo LE, Barbeito CG, Zanuzzi CN, Portiansky EL, Gimeno EJ. Calbindin D28k expression and the absence of apoptosis in the cerebellum of Solanum bonariense L-intoxicated bovines. Vet Pathol 2009; 47:569-72. [PMID: 20234028 DOI: 10.1177/0300985809358040] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Solanum bonariense intoxication is characterized by cerebellar neuronal vacuolation, degeneration, and necrosis. Cerebellar Purkinje cells seem especially susceptible, but more research is needed to determine the pathogenesis of neuronal necrosis and the mechanism of Purkinje cell susceptibility. Calbindin D28k (CbD28k) is highly expressed in Purkinje cells and has been used as a marker for normal and degenerative Purkinje cells. The goal of this study was to describe S bonariense-induced disease by ascertaining Purkinje cell-specific degenerative changes using CbD28k expression and to correlate this with apoptosis in Purkinje cells, as determined using TUNEL (transferase-mediated dUTP-biotin nick end-labeling) and ultrastructural changes. In all cases, an increase in both dose and duration of S bonariense intoxication resulted in a decrease in the number of Purkinje cells. CbD28k immunohistochemistry was an excellent marker for Purkinje cells because immunoreactivity did not change in normal or degenerative tissues. This finding suggests that excessive calcium excitatory stimulation does not induce rapid neuronal degeneration and death. As found in previous studies, TUNEL tests and electron microscopy suggest that Purkinje cell degeneration and death are not occurring via an apoptotic process. These findings suggest that S bonariense poisoning induces progressive Purkinje cell death that is not mediated by excitotoxicity or apoptotic activation.
Collapse
|